LSL Pharma Group Inc. (LSL.V)
- Previous Close
0.4050 - Open
0.4100 - Bid 0.3900 x --
- Ask 0.4200 x --
- Day's Range
0.4000 - 0.4100 - 52 Week Range
0.3500 - 0.5900 - Volume
11,000 - Avg. Volume
38,991 - Market Cap (intraday)
39.408M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0500 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
LSL Pharma Group Inc. engages in the development, manufacture, and distribution of natural health products and dietary supplements in solid dosage forms and sterile ophthalmic pharmaceutical products. The company is based in Boucherville, Canada.
www.laboratoirelsl.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: LSL.V
Performance Overview: LSL.V
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LSL.V
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LSL.V
Valuation Measures
Market Cap
39.41M
Enterprise Value
49.68M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.25
Price/Book (mrq)
4.04
Enterprise Value/Revenue
5.91
Enterprise Value/EBITDA
-13.75
Financial Highlights
Profitability and Income Statement
Profit Margin
-124.30%
Return on Assets (ttm)
-13.55%
Return on Equity (ttm)
-119.74%
Revenue (ttm)
8.86M
Net Income Avi to Common (ttm)
-11.01M
Diluted EPS (ttm)
-0.0500
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
142.38%
Levered Free Cash Flow (ttm)
-4.18M
Company Insights: LSL.V
LSL.V does not have Company Insights